The Canadian Press on MSN
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...
A well-structured plan provides a roadmap for care, helps prevent crises, and ensures that your loved one’s dignity and quality of life remain central to every decision.
In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.
GB News on MSN
Pharmacist names three drugs he would never touch as they 'wreak havoc' and 'destroy cartilage'
A Texas pharmacist has sparked conversation on TikTok by revealing three widely used prescription drugs he personally refuses ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...
Breast cancer survivors had a slightly lower risk of Alzheimer's dementia than cancer-free controls in Korea. Radiation therapy, but not other treatments, was tied to reduced Alzheimer's dementia risk ...
For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results